Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
针对 SIV 和 HIV 疫苗的抗原特异性 NK 细胞记忆
基本信息
- 批准号:10408910
- 负责人:
- 金额:$ 3.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Natural killer (NK) cells provide rapid early responses to viral infections and thus can contribute
substantially to disease modulation and vaccine protection. Traditionally, NK cells have been
considered to be nonspecific components of innate immunity, but recent studies in mice have
shown that NK cells can also demonstrate features of antigen-specific memory. Until recently it
was unclear whether this phenomenon might exist in primates, but our preliminary data
demonstrates for the first time evidence of antigen-specific NK cell memory in any
primate species. As compared with NK cells from uninfected macaques, splenic and hepatic
NK cells from simian immunodeficiency virus (SIV)-infected animals were highly reactive to
Gag- and Env-pulsed dendritic cells (DCs) but not to mock-pulsed DCs or mis-matched antigen
controls. Similar Gag-specific NK cell responses were found in treated and untreated HIV-1-
infected patients. Interestingly, memory NK cell responses in peripheral blood were low
compared to distal sites, suggesting memory NK cells reside predominantly in tissues. We also
found NK cell memory responses in rhesus macaques for over 5 years following vaccination
with recombinant Ad26 vectors expressing HIV-1 Env or SIV Gag indicating antigen-specific
NK cell memory is durable and does not require ongoing antigenic stimulation. The
longevity, functionality, and specificity of memory NK cell responses in primates suggest their
functional relevance and their potential importance against HIV-1 and other pathogens. In this
new proposal we will address major deficits to this new field of study including identifying the
mechanisms, kinetics, distribution, and efficacy of these responses using state-of-the-art
techniques. We will evaluate the overarching hypothesis that memory NK cell responses
elicited against SIV/HIV and adenovirus vaccine vectors are long-lived even in the absence of
replicating virus and can be mobilized to engage and lyse virus-infected cells in an antigen-
specific manner. We will evaluate this hypothesis with three focused Specific Aims: (1) Evaluate
mobilization and recall of memory NK cells elicited against HIV and SIV vaccine antigens
in humans and macaques; (2) Evaluate mobilization and maintenance of memory NK
cells after SIV challenge in vaccinated and unvaccinated macaques; and (3) Explore
cellular and molecular mechanisms of memory NK cell recognition and specificity.
自然杀伤(NK)细胞对病毒感染提供快速的早期反应,
基本上用于疾病调节和疫苗保护。传统上,
被认为是先天免疫的非特异性成分,但最近在小鼠中的研究表明,
表明NK细胞也可以表现出抗原特异性记忆的特征。直到最近它
目前还不清楚这种现象是否存在于灵长类动物中,但我们的初步数据显示,
首次证明了在任何免疫系统中抗原特异性NK细胞记忆的证据。
灵长类动物与未感染猕猴的NK细胞相比,
来自猴免疫缺陷病毒(SIV)感染动物的NK细胞对
Gag和Env脉冲的树突状细胞(DC),但不与模拟脉冲的DC或错配抗原
对照在治疗的和未治疗的HIV-1-1中发现了类似的GAG特异性NK细胞应答。
感染的病人。有趣的是,外周血中的记忆NK细胞应答较低,
与远端部位相比,提示记忆NK细胞主要存在于组织中。我们也
在恒河猴中发现NK细胞记忆反应,在接种疫苗后超过5年
用表达HIV-1 Env或SIV Gag的重组Ad 26载体表明抗原特异性
NK细胞记忆是持久的,不需要持续的抗原刺激。的
灵长类动物记忆NK细胞应答的寿命、功能和特异性表明,
功能相关性及其对HIV-1和其他病原体的潜在重要性。在这
我们将解决这一新研究领域的主要不足,包括确定
这些反应的机制、动力学、分布和功效,
技术.我们将评估记忆NK细胞反应的总体假设,
针对SIV/HIV和腺病毒的疫苗载体即使在缺乏
复制病毒,并且可以被动员以在抗原中接合和裂解病毒感染的细胞,
具体方式。我们将通过三个重点具体目标来评估这一假设:(1)评估
HIV和SIV疫苗抗原诱导的记忆NK细胞的动员和回忆
在人类和猕猴中;(2)评估NK细胞的记忆动员和维持
在接种疫苗和未接种疫苗的猕猴中SIV攻击后的细胞;和(3)探索
记忆NK细胞识别和特异性的细胞和分子机制。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger Keith Reeves其他文献
Roger Keith Reeves的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger Keith Reeves', 18)}}的其他基金
Microbial and innate immune mechanisms of oral inflammation during SIV infection
SIV感染期间口腔炎症的微生物和先天免疫机制
- 批准号:
10408915 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10319735 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
- 批准号:
10408913 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10458737 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
- 批准号:
10305659 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
- 批准号:
10529270 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10626025 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
表达自然杀伤细胞受体的 B 细胞作为 SIV 感染粘膜免疫的调节剂
- 批准号:
10451069 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
表达自然杀伤细胞受体的 B 细胞作为 SIV 感染粘膜免疫的调节剂
- 批准号:
9927204 - 财政年份:2019
- 资助金额:
$ 3.66万 - 项目类别:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
针对 SIV 和 HIV 疫苗的抗原特异性 NK 细胞记忆
- 批准号:
9405715 - 财政年份:2017
- 资助金额:
$ 3.66万 - 项目类别:
相似国自然基金
花胶鱼类物种Species-specific PCR和Multiplex PCR鉴定体系研究
- 批准号:31902373
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
在病毒治疗过程中积极参与 NK 细胞诱导新抗原特异性抗肿瘤免疫
- 批准号:
10646382 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Prize 202203PJT - IFN-alpha subtype specific effects on NK cells during HIV-1 infection
奖 202203PJT - HIV-1 感染期间 IFN-α 亚型对 NK 细胞的特异性影响
- 批准号:
467991 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Operating Grants
IFN-alpha subtype specific effects on NK cells during HIV-1 infection
HIV-1 感染期间 IFN-α 亚型对 NK 细胞的特异性影响
- 批准号:
461704 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Operating Grants
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
在病毒治疗过程中积极参与 NK 细胞诱导新抗原特异性抗肿瘤免疫
- 批准号:
10405290 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Single cell gene expression profiling of NK cell specific Regnase-1 conditional knock-out mice
NK 细胞特异性 Regnase-1 条件敲除小鼠的单细胞基因表达谱
- 批准号:
20K22777 - 财政年份:2020
- 资助金额:
$ 3.66万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of Chemical Immunotherapeutic Bi-Specific NK and T cell Engagers
化学免疫治疗双特异性 NK 和 T 细胞接合剂的开发
- 批准号:
541271-2019 - 财政年份:2019
- 资助金额:
$ 3.66万 - 项目类别:
University Undergraduate Student Research Awards
Effects of NK cell adaptation to cytomegalovirus and engagement of TIGIT on HIV-specific antibody-dependent cell-mediated cytotoxicity
NK 细胞对巨细胞病毒的适应和 TIGIT 参与对 HIV 特异性抗体依赖性细胞介导的细胞毒性的影响
- 批准号:
400251 - 财政年份:2019
- 资助金额:
$ 3.66万 - 项目类别:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
针对 SIV 和 HIV 疫苗的抗原特异性 NK 细胞记忆
- 批准号:
9405715 - 财政年份:2017
- 资助金额:
$ 3.66万 - 项目类别:
Tumor-specific CAR-NK cells for adoptive cancer immunotherapy
用于过继性癌症免疫治疗的肿瘤特异性 CAR-NK 细胞
- 批准号:
350733817 - 财政年份:2017
- 资助金额:
$ 3.66万 - 项目类别:
Research Grants
Defining the bio-molecular features of pigment cell-specific NK cell memory
定义色素细胞特异性 NK 细胞记忆的生物分子特征
- 批准号:
320398819 - 财政年份:2016
- 资助金额:
$ 3.66万 - 项目类别:
Priority Programmes